Furans
Medchemexpress LLC PF-04634817 succinate | 2140301-98-8 | 99.5% | 629.67 | C29H42F3N5O7 | 5 MG
PF-04634817 succinate is a research-grade small molecule dual CCR2/CCR5 chemokine receptor antagonist supplied as the succinate salt in a white to off-white solid. It is orally active in preclinical models, displays potent CCR2 activity (rat IC50 ≈ 20.8 nM) with lower CCR5 potency (rat IC50 ≈ 470 nM), and is intended for laboratory research use only.
- Dual CCR2/CCR5 antagonist activity (rat CCR2 IC50 ≈ 20.8 nM; CCR5 IC50 ≈ 470 nM).
- High purity (~99.5%).
- Supplied as a succinate salt in solid form.
- Molecular weight 629.67 Da.
- Intended for in vitro and in vivo research; not for human use.
- Available in 5 mg package size.
Aobchem 2-(5-Methyl-2-furanyl)benzaldehyde | ≥95% | CAS 400746-82-9 | C12H10O2 | 1g
2-(5-Methyl-2-furanyl)benzaldehyde | ≥95% | CAS 400746-82-9 | C12H10O2 | 1g
Apexbio Technology LLC Terlipressin diacetate 1884420-36-3 10mg
Terlipressin diacetate (CAS 1884420-36-3) is a synthetic analogue of vasopressin classified as a vasopressin receptor agonist It exhibits high selectivity for V1 receptors localized on vascular smooth muscle where it induces pronounced vasoconstriction by activating the phospholipase C inositol 1 4 5-trisphosphate (IP3) signaling pathway This leads to increased vascular resistance and elevated blood pressure Terlipressin diacetate is widely utilized in biomedical research investigating mechanisms of vascular tone regulation hemodynamic response in portal hypertension and pathophysiology of conditions such as variceal bleeding and hepatorenal syndrome
Medchemexpress LLC Bv02 | 292870-53-2 | MFCD00356631 | 99.8% | 377.36 g/mol | C20H15N3O5 | 10 MG
BV02 is a small-molecule inhibitor of 14-3-3 protein-protein interactions used in preclinical research to study apoptosis, autophagy, Akt signaling, and host-pathogen responses. It is provided for in vitro experiments in solid form and as a DMSO solution.
- High chemical purity (≈99.8%).
- Well-defined molecular formula C20H15N3O5 and molecular weight 377.36 g/mol.
- Indexed by CAS number 292870-53-2 for unambiguous identification.
- Available in multiple solid sizes and as a 10 mM solution in DMSO for assay readiness.
- Reported to modulate PARP and caspase-3 cleavage and to affect Akt signaling in cell studies.
- Supplied for research use only; not for human or veterinary use.
Medchemexpress LLC 7-TFA-ap-7-Deaza-dA | 178420-75-2 | 98.8% | 399.32 | 100 MG
7-TFA-ap-7-Deaza-dA is a modified nucleoside and a click chemistry reagent. It is utilized in the synthesis of deoxyribonucleic acid or nucleic acid. Featuring an alkyne group, this compound is capable of undergoing copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. It is intended for laboratory use and substance manufacturing, strictly for research purposes.
- Modified nucleoside
- Click chemistry reagent
- Contains an alkyne group for CuAAc reactions
- Supports DNA and nucleic acid synthesis
- For laboratory chemicals and substance manufacturing
- For research use only
Medchemexpress LLC Nitrofurantoin (Standard) | 67-20-9 | 99.74% | C8H6N4O5 | 25 MG
Nitrofurantoin (Standard) is an analytical standard primarily intended for research and analytical applications. This potent, orally active, broad-spectrum beta-lactamase antimicrobial agent functions as an antibiotic, making it suitable for the study of urinary tract infections (UTIs), including cystitis and kidney infections.
- Analytical standard for research and analytical applications
- Potent and orally active
- Broad-spectrum beta-lactamase antimicrobial agent
- Effective as an antibiotic
- Useful for studying urinary tract infections (UTIs), including cystitis and kidney infections
Medchemexpress LLC Selank diacetate 5mg | 5MG
Selank (Selanc) acetate is a synthetic peptide derived from tuftsin Selank acetate has anxiolytic activity and is a nootropic neuropsychotropic antidepressant and antistress compound[1
Medchemexpress LLC BMS-911172 100mg | 1644248-18-9 | 339.34 | C16H19F2N3O3 | 100 MG
BMS-911172 is a small-molecule inhibitor of adaptor-associated kinase 1 (AAK1) with a reported IC50 of 35 nM; it is supplied for laboratory research use only.
- Inhibits AAK1 with IC50 of 35 nM
- Reported purity 99.49%
- Available in multiple solid sizes and 10 mM DMSO solutions
- Suitable for in vitro and preclinical research; not for human use
- Molecular weight 339.34 g/mol; formula C16H19F2N3O3
- Certificate of analysis and safety data sheet available
Medchemexpress LLC Linperlisib | 1702816-75-8 | MFCD31544346 | 98.9% | 588.69 g·mol⁻¹ | C28H37FN6O5S | 25 MG
Linperlisib is a potent, orally bioavailable, and selective inhibitor of phosphoinositide 3-kinase delta (PI3Kδ) developed for research applications. It demonstrates an IC50 of approximately 6.4 nM against PI3Kδ and is supplied as a high-purity solid suitable for in vitro and preclinical studies.
- Potent, selective inhibitor of PI3Kδ (IC50 ≈ 6.4 nM).
- Orally bioavailable profile useful for in vivo studies.
- Supplied as a high-purity solid (≈98.9%).
- Suitable for in vitro and preclinical research applications.
- Available in multiple small-scale quantities for laboratory use.
- Recommended storage at low temperatures to preserve stability.
Medchemexpress LLC 1-Aminohydantoin hydrochloride | 2827-56-7 | MFCD02181047 | >98.0% | 151.55 g/mol | C3H6ClN3O2 | 25mg
1-Aminohydantoin hydrochloride (Standard) is the analytical standard of 1-Aminohydantoin hydrochloride (HY-Y0469) This product is intended for research and analytical applications 1-Aminohydantoin hydrochloride is a major metabolite of Nitrofurantoin (HY-A0090) in animal tissues and can be used as a standard for the determination of residues of veterinary agents in meat milk et al 1-Aminohydantoin hydrochloride covalently binds to tissue proteins and is released from the tissues under slightly acidic conditions and derivatized with 2-nitrobenzaldehyde to form nitrophenyl derivatives of 1-Aminohydantoin hydrochloride before detection[1][2]
Medchemexpress LLC ATH686 | 853299-52-2 | 99.54% | 515.53 | 5 MG
ATH686 is a potent, selective, and ATP-competitive FLT3 inhibitor that targets mutant FLT3 protein kinase activity. It inhibits the proliferation of cells harboring FLT3 mutants by inducing apoptosis and cell cycle inhibition, also exhibiting antileukemic effects.
- Potently inhibits cell proliferation (IC50 around 0.001 μM) in FLT3-ITD-Ba/F3 cells and D835Y-Ba/F3 cells
- Induces apoptosis
- Inhibits autophosphorylation of mutant FLT3
- Exhibits antileukemic effects